While the premarket approval process has been delegated by most of the competent authorities to the private sector, competent authorities have kept the responsibility for the surveillance of their market. Because of this situation, there is transfer of resource and energy to the monitoring of market including the vigilance system within each member state. The evaluation of incidents notified by the manufacturers and users represents a key source of information. Combined with sophisticated exchange of information between EU member states, and also with other countries like the U.S., Japan, Canada, or Australia, this provides a unique insight of the performance of devices in the post production phase.
EC Medical Devices Vigilance Systems and Post Marketing Surveillance
Jan 22nd, 2008Jan 23rd, 2008
London, --
GB
Latest in Home










![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)




